Derrick Rossi, CEO, Convelo Therapeutics & Co-founder, Moderna Therapeutics

Dr. Rossi is a serial biotech entrepreneur and leading stem cell scientist. His efforts in the development of cutting-edge technologies and new therapeutic strategies are at the forefront of regenerative medicine and biotechnology. Time magazine named Dr. Rossi as one of the 100 Most Influential People in the world (Time 100) in 2011.

Dr. Rossi earned his BSc and MSc from University of Toronto, and his PhD from the University of Helsinki. He was an Associate Professor at Harvard Medical School and Harvard University and an investigator at Boston Children’s Hospital where he led an academic team working on stem cell biology and regenerative medicine. Discoveries made in Dr. Rossi’s lab have led to the formation of several leading biotechnology companies. His development of modified-mRNA reprogramming was named by Time magazine as one of the top ten medical breakthroughs of 2010. That same year, Dr. Rossi leveraged that technology to found Moderna Therapeutics, a clinical-stage company developing modified-mRNA therapeutics that is now a leader in the COVID-19 vaccine race.

Amber Kanwar, Anchor & Reporter, BNN Bloomberg

Amber Kanwar is an anchor and reporter appearing on BNN Bloomberg’s flagship morning show The Open. She is a relentless digger, always looking for ways to break news and bring exclusive information and insight to BNN Bloomberg’s audience.

With a decade of business reporting experience, Amber specializes in equity markets and is constantly seeking out stocks flying under the radar, trends that are about to emerge, and curating research to make it accessible to viewers. She is a leader in breaking news and has interviewed CEOs from across Canada’s C-Suite.